Ahmedabad-based pharmaceutical major Cadila Healthcare (Zydus Cadila) has posted a 7.3% dip in net profit for the quarter ended September 30, 2012 to Rs 95.1 crore from Rs 102.6 crore in the corresponding quarter last fiscal. This includes minority interest and share of profit of associates, the company added in its release to the Bombay Stock Exchange.
Total income for the period, however, grew by 24.58% to Rs 1,554.1 crore during the quarter under review as against Rs 1,247.4 crore in the second quarter of the last financial year.
The company's share prices were down 3.1% to Rs 859.20 on BSE at the end of day's trade.
Top Section
Explore Business Standard